These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 25704281)

  • 41. Postoperative pro-adrenomedullin levels predict mortality in thoracic surgery patients: comparison with Acute Physiology and Chronic Health Evaluation IV Score*.
    Schoe A; Schippers EF; Struck J; Ebmeyer S; Klautz RJ; de Jonge E; van Dissel JT
    Crit Care Med; 2015 Feb; 43(2):373-81. PubMed ID: 25599464
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The prognostic value of MR-proadrenomedullin in patients with acute coronary syndrome complicated by cardiogenic shock.
    Supeł K; Kacprzak M; Zielińska M
    Biomarkers; 2017; 22(3-4):296-303. PubMed ID: 27788594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Pulmonary tuberculosis mimicking a severe community-acquired pneumonia with rhabdomyolysis].
    Tedesco A; Guglielmetti L; Conti M; Cazzadori A; Concia E
    Infez Med; 2013 Jun; 21(2):146-8. PubMed ID: 23774981
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Community-acquired pneumonia.
    Musher DM; Spindel SJ
    Curr Clin Top Infect Dis; 1996; 16():102-24. PubMed ID: 8714250
    [No Abstract]   [Full Text] [Related]  

  • 45. Serum procalcitonin level: clinical significance.
    Aggarwal D; Mohapatra PR; Aggarwal P
    Eur Respir J; 2011 Mar; 37(3):723; author reply 723. PubMed ID: 21357930
    [No Abstract]   [Full Text] [Related]  

  • 46. Prediction about severity and outcome of sepsis by pro-atrial natriuretic peptide and pro-adrenomedullin.
    Wang RL; Kang FX
    Chin J Traumatol; 2010 Jun; 13(3):152-7. PubMed ID: 20515592
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Case of the month: diagnostic challenges from your case files.
    Burney M; Reynolds S
    JAAPA; 2004 Dec; 17(12):52. PubMed ID: 15631021
    [No Abstract]   [Full Text] [Related]  

  • 48. Proadrenomedullin as a prognostic marker in neonatal sepsis.
    Oncel MY; Dilmen U; Erdeve O; Ozdemir R; Calisici E; Yurttutan S; Canpolat FE; Oguz SS; Uras N
    Pediatr Res; 2012 Nov; 72(5):507-12. PubMed ID: 22885414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Connecting the Dots-Acute Abdomen, ST Elevation, and a Consolidating Lung Mass.
    Kennedy R; Adonteng-Boateng P
    Am J Med; 2019 Mar; 132(3):e517-e518. PubMed ID: 30503883
    [No Abstract]   [Full Text] [Related]  

  • 50. Procalcitonin, MR-Proadrenomedullin, and Cytokines Measurement in Sepsis Diagnosis: Advantages from Test Combination.
    Angeletti S; Dicuonzo G; Fioravanti M; De Cesaris M; Fogolari M; Lo Presti A; Ciccozzi M; De Florio L
    Dis Markers; 2015; 2015():951532. PubMed ID: 26635427
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Time course of proadrenomedullin in the early phase of septic shock. A comparative study with other proinflammatory proteins.
    Pezzilli R; Barassi A; Pigna A; Morselli-Labate AM; Imbrogno A; Fabbri D; Di Nino G; Corinaldesi R; Melzi D'Eril G
    Panminerva Med; 2012 Sep; 54(3):211-7. PubMed ID: 22801438
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism.
    Pedowska-Włoszek J; Kostrubiec M; Kurnicka K; Ciurzynski M; Palczewski P; Pruszczyk P
    Thromb Res; 2013 Nov; 132(5):506-10. PubMed ID: 24060192
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blood Midregional Proadrenomedullin as a Hemodynamic Severity Marker in Asymptomatic Carotid Artery Stenosis/Occlusion.
    Hattori Y; Kakino Y; Kiyoshige E; Ogata S; Nishimura K; Iida H; Ihara M
    Stroke; 2024 Jul; 55(7):e182-e184. PubMed ID: 38860369
    [No Abstract]   [Full Text] [Related]  

  • 54. Dysnatremia, vasopressin, atrial natriuretic peptide and mortality in patients with community-acquired pneumonia: results from the german competence network CAPNETZ.
    Krüger S; Ewig S; Giersdorf S; Hartmann O; Frechen D; Rohde G; Suttorp N; Welte T;
    Respir Med; 2014 Nov; 108(11):1696-705. PubMed ID: 25306251
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Biomarkers in community acquired pneumonia - what did we learn from the CAPNETZ study?].
    Krüger S; Pletz MW; Rohde G
    Pneumologie; 2011 Feb; 65(2):110-3. PubMed ID: 21117019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Predictors of severe sepsis among patients hospitalized for community-acquired pneumonia.
    Montull B; Menéndez R; Torres A; Méndez R
    MLO Med Lab Obs; 2016 Mar; 48(3):8, 10-2; quiz 14. PubMed ID: 27116802
    [No Abstract]   [Full Text] [Related]  

  • 57. Is pro-adrenomedullin a more useful marker in hospitalized infants with sepsis?
    Oncel MY; Erdeve O; Uras N; Dilmen U
    Eur J Pediatr; 2014 Jan; 173(1):127-8. PubMed ID: 23955488
    [No Abstract]   [Full Text] [Related]  

  • 58. [Extrapulmonary manifestations of community acquired pneumonia].
    Bascir G; Aguilar AM; Abbet P
    Rev Med Suisse; 2014 Oct; 10(445):1876, 1878-81. PubMed ID: 25417358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Usefulness and prognostic value of biomarkers in patients with community-acquired pneumonia in the emergency department.
    Julián-Jiménez A; González Del Castillo J; Candel FJ
    Med Clin (Barc); 2017 Jun; 148(11):501-510. PubMed ID: 28391994
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit.
    Heining L; Giesa C; Ewig S
    Lung; 2016 Apr; 194(2):185-91. PubMed ID: 26748496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.